Literature DB >> 24643843

Planned Analyses of the REDUCE MRSA Trial.

Susan S Huang1, Richard Platt.   

Abstract

Mesh：

Year:  2014        PMID： 24643843      PMCID： PMC4023732          DOI： 10.1128/AAC.02792-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  2 in total

1.  A perspective on how the United States fell behind Northern Europe in the battle against methicillin-resistant Staphylococcus aureus.

Authors:  Kevin T Kavanagh; Daniel M Saman; Yanling Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

2.  Targeted versus universal decolonization to prevent ICU infection.

Authors:  Susan S Huang; Edward Septimus; Ken Kleinman; Julia Moody; Jason Hickok; Taliser R Avery; Julie Lankiewicz; Adrijana Gombosev; Leah Terpstra; Fallon Hartford; Mary K Hayden; John A Jernigan; Robert A Weinstein; Victoria J Fraser; Katherine Haffenreffer; Eric Cui; Rebecca E Kaganov; Karen Lolans; Jonathan B Perlin; Richard Platt
Journal:  N Engl J Med       Date:  2013-05-29       Impact factor: 91.245
  2 in total
  3 in total

1.  Reply to "Planned analyses of the REDUCE MRSA Trial".

Authors:  Kevin T Kavanagh; Daniel M Saman; Yanling Yu
Journal:  Antimicrob Agents Chemother       Date:  2014       Impact factor: 5.191

2.  Viewpoint: a response to "Screening and isolation to control methicillin-resistant Staphylococcus aureus: sense, nonsense, and evidence".

Authors:  Kevin T Kavanagh; Lindsay E Calderon; Daniel M Saman
Journal:  Antimicrob Resist Infect Control       Date:  2015-02-05       Impact factor: 4.887

3.  A Perspective on the Principles of Integrity in Infectious Disease Research.

Authors:  Kevin T Kavanagh; Stephen S Tower; Daniel M Saman
Journal:  J Patient Saf       Date:  2016-06       Impact factor: 2.844
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.